NASDAQ:STOK | Profit Breakdown | Stoke Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$9.33M-$65.43M-$61.62M-$61.62M
2026-03-31$6.23M-$53.42M-$50M-$50M
2025-12-31$1.4M-$61.44M-$57.93M
2025-09-30$10.63M-$43.09M-$39.63M-$38.35M
2025-06-30$13.82M-$27.3M-$23.48M-$23.48M
2025-03-31$158.57M$111.24M$114.16M$112.88M
2024-12-31$22.61M-$13.65M-$10.48M
2024-09-30$4.89M-$30M-$26.43M-$26.43M
2024-06-30$4.83M-$29.34M-$25.7M-$25.7M
2024-03-31$4.22M-$28.37M-$26.37M-$26.37M
2023-12-31$2.8M-$29.59M-$26.96M
2023-09-30$3.31M-$27.23M-$24.54M
2023-06-30-$2.48M-$33.26M-$30.65M
2023-03-31$5.15M-$24.69M-$22.55M
2022-12-31$3.27M-$27.18M-$25.66M
2022-09-30$2.91M-$27.15M-$26.11M
2022-06-30$3.23M-$25.24M-$24.65M
2022-03-31$3M-$24.8M-$24.65M
2021-12-31-$24.53M-$24.45M
2021-09-30-$22.68M-$22.6M
2021-06-30-$22.03M-$21.97M
2021-03-31-$16.83M-$16.79M
2020-12-31-$14.59M-$14.56M
2020-09-30-$13.71M-$13.68M
2020-06-30-$13.01M-$12.96M
2020-03-31-$11.74M-$11.04M
2019-12-31-$11.07M-$10.16M
2019-09-30-$9.84M-$8.6M
2019-06-30-$8.45M-$7.82M
2019-03-31-$6.32M-$5.74M
2018-12-31-$4.54M-$4.28M
2018-09-30-$3.32M-$3.32M
2018-06-30-$3.01M-$3.01M
2018-03-31-$1.91M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$184.42M-$20.59M-$6.89M
2024-12-31$36.56M-$101.37M-$88.98M
2023-12-31$8.78M-$114.77M-$104.7M
2022-12-31$12.41M-$104.36M-$101.07M
2021-12-31-$86.07M-$85.81M
2020-12-31-$53.04M-$52.24M
2019-12-31-$35.68M-$32.33M
2018-12-31-$12.78M-$12.52M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.